Humana/$HUM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Humana
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
- Ticker
- $HUM
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 67,060
- Headquarters
- Louisville, United States
- Website
- www.humana.com
Humana Metrics
BasicAdvanced
$50B
39.02
$10.59
0.75
$3.54
0.86%
Price and volume
Market cap
$50B
Beta
0.75
52-week high
$456.50
52-week low
$163.11
Average daily volume
1.4M
Dividend rate
$3.54
Financial strength
Current ratio
1.742
Quick ratio
1.285
Long term debt to equity
0.629
Total debt to equity
0.757
Dividend payout ratio (TTM)
33.62%
Interest coverage (TTM)
4.76%
Profitability
EBITDA (TTM)
3,596
Gross margin (TTM)
13.65%
Net profit margin (TTM)
0.88%
Operating margin (TTM)
2.30%
Effective tax rate (TTM)
18.71%
Revenue per employee (TTM)
$2,170,000
Management effectiveness
Return on assets (TTM)
3.90%
Return on equity (TTM)
6.89%
Valuation
Price to earnings (TTM)
39.021
Price to revenue (TTM)
0.341
Price to book
2.58
Price to tangible book (TTM)
6.57
Price to free cash flow (TTM)
25.492
Free cash flow yield (TTM)
3.92%
Free cash flow per share (TTM)
16.208
Dividend yield (TTM)
0.86%
Forward dividend yield
0.86%
Growth
Revenue change (TTM)
18.33%
Earnings per share change (TTM)
-18.81%
3-year revenue growth (CAGR)
13.85%
10-year revenue growth (CAGR)
10.33%
3-year earnings per share growth (CAGR)
-26.62%
10-year earnings per share growth (CAGR)
4.99%
3-year dividend per share growth (CAGR)
1.91%
10-year dividend per share growth (CAGR)
11.80%
What the Analysts think about Humana
Analyst ratings (Buy, Hold, Sell) for Humana stock.
Analyst projections of the future price of Humana stock.
Bulls say / Bears say
Humana reported that 95% of its Medicare Advantage members are in plans rated at least four stars for 2027, and that its results exceeded its top-quartile target for 2028 bonus revenue. This could strengthen future payments, although the financial benefit depends on membership and plan mix. (Humana, StockTitan)
Humana reaffirmed its forecast for about 25% growth in individual Medicare Advantage membership in 2026 and at least $9 in adjusted EPS. Its second-quarter insurance benefit ratio was 91.2%, in line with management’s expectations, supporting the case that growth is progressing without a guidance reset. (Humana)
CenterWell Senior Primary Care added 130,900 patients in the first half of 2026, a 27% increase, and Humana won a statewide Illinois Medicaid contract due to start in 2027. These businesses offer growth alongside its core Medicare insurance operations. (Humana)
Humana’s second-quarter insurance benefit ratio rose to 91.2% from 89.7% a year earlier, and its full-year forecast is 92.75%, plus or minus 25 basis points. Persistently high medical costs could therefore leave little room for earnings to improve. (Humana)
Humana plans to exit Medicare Advantage plans covering about 600,000 members for 2027 and expects to recapture only around 40% in its remaining plans. The resulting loss of members could offset some of the growth it has recently achieved. (Healthcare Finance News)
The 2027 star-rating rebound does not remove the near-term earnings drag: Humana says its 2026 adjusted EPS guidance of at least $9 reflects a year-on-year decline from the 2026 bonus-year rating shortfall. The company also says some 2028 star-rating revenue above its top-quartile goal will be one-off, so sustained gains are not assured. (Humana, StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2026.
Humana Financial Performance
Revenues and expenses
Humana Earnings Performance
Company profitability
Upcoming events
Humana News
AllArticlesVideos
Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga5 days ago
Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
Business Wire5 days ago
Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
Business Wire5 days ago
Funds containing Humana
AllUSDEURGBP
Fund name | Fund size | $HUM weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced£WHCA | $362M | 0.89% |
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 0.89% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.81% |
Invesco Health Care S&P US Select Sector$XLVS | $552M | 0.80% |
SPDR MSCI World Health Care$WHEA | $708M | 0.60% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.